(Q26781451)

English

Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid Angiopathy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid Angiopathy (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

0 references

Alzheimer's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cerebral amyloid angiopathy

1 reference

based on heuristic

inferred from title

Jacopo C. DiFrancesco

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Fabrizio Piazza

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Martina Longoni

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

language of work or name

0 references

publication date

25 September 2015

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Frontiers in Neurology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

207

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

7 April 2017

Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Cerebral Amyloid Angiopathy Associated with Inflammation: Report of 3 Cases and Systematic Review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Stroke-Like Episodes Heralding a Reversible Encephalopathy: Microbleeds as the Key to the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation-A Case Report and Literature Review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

The Inflammatory Form of Cerebral Amyloid Angiopathy or "Cerebral Amyloid Angiopathy-Related Inflammation" (CAARI).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Cerebral amyloid angiopathy: emerging concepts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Reduced levels of amyloid beta-peptide antibody in Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

28 September 2017

Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

31 May 2018

Mystery case: cerebral amyloid angiopathy-related inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585101

31 May 2018

MR imaging features of amyloid-related imaging abnormalities.

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

ARIA from off-key operas?

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA?

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies.

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Clinical manifestations of cerebral amyloid angiopathy-related inflammation

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Course of cerebral amyloid angiopathy-related inflammation.

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Amyloid-related imaging abnormalities in AβPP duplication carriers

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Spontaneous ARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in presenilin 1-associated familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Multiple Spontaneous Cerebral Microbleeds and Leukoencephalopathy in PSEN1-Associated Familial Alzheimer's Disease: Mirror of Cerebral Amyloid Angiopathy?

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Serum anti-amyloid-beta antibodies and Alzheimer's disease in elderly Korean patients

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer's disease and control subjects

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Autoantibodies to amyloid-beta and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Immune activation in amyloid-β-related angiitis correlates with decreased parenchymal amyloid-β plaque load.

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Brain-reactive β-amyloid antibodies in primary CNS angiitis with cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

¹¹C-PiB PET imaging of encephalopathy associated with cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.3389%2FFNEUR.2015.00207

21 January 2018

Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26441825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-A autoantibodies in the CSF of a patient with CAA-related inflammation: A case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/26441825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/26441825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased Soluble APPα, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26441825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26441825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Life imitates art: anti-amyloid antibodies and inflammatory cerebral amyloid angiopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26441825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3389/FNEUR.2015.00207

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

release_ufsd2ruemnfk5lp2bqh3cedxtu

1 reference

https://api.fatcat.wiki/v0/release/ufsd2ruemnfk5lp2bqh3cedxtu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26441825%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26781451&oldid=1842279269"